China Gewang Biotechnology (CGWB) 10-Q 2017 Q2 Quarterly report

EXHIBIT 32: Rule 13a-14(b) Certification

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the undersigned officers of China Gewang Biotechnology, Inc. (the “Company”) certify that:

1.    The Quarterly Report on Form 10-Q of the Company for the period ended February 28, 2017 (the “Report”) fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)); and

2.    The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: July 17, 2017	By:	/s/ Li Wang
		Li Wang, Chief Executive Officer

Date: July 17, 2017	By:	/s/ Ming Cheng
		Ming Cheng, Chief Financial Officer